title: [Effects on lipid metabolism of inhibitors of cholesterol synthesis].
authors.forename: G
authors.initials: G
authors.lastname: Guarini
authors.forename: C
authors.initials: C
authors.lastname: Costa
authors.forename: C
authors.initials: C
authors.lastname: Trimarco
authors.forename: D
authors.initials: D
authors.lastname: Santese
authors.forename: E
authors.initials: E
authors.lastname: Vitaliano
mesh_terms: D000368:Aged; D000924:Anticholesteremic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D002784:Cholesterol / Q000097:blood; D002986:Clinical Trials as Topic; D002994:Clofibrate / Q000494:pharmacology; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D006937:Hypercholesterolemia / Q000097:blood / Q000188:drug therapy; D050356:Lipid Metabolism; D008055:Lipids / Q000097:blood; D008148:Lovastatin / Q000494:pharmacology; D008297:Male; D008875:Middle Aged; D009525:Niacin / Q000494:pharmacology; D014280:Triglycerides / Q000097:blood
chemical_list: D000924:Anticholesteremic Agents; D008055:Lipids; D014280:Triglycerides; D009525:Niacin; D002784:Cholesterol; D008148:Lovastatin; D002994:Clofibrate
vernacular_title: Sugli effetti lipometabolici di alcuni inibitori della sintesi del colesterolo.